HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) All Versions of this Article: hrt.2006.095232v1 93/6/711    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Nasermoaddeli, A. Articles by Nakagawa, H. Search for Related Content PubMed PubMed Citation Articles by Nasermoaddeli, A. Articles by Nakagawa, H.

Prognosis and prognostic factors in patients with hypertrophic cardiomyopathy in Japan: results from a nationwide study

¹ Department of Epidemiology and Public Health, Kanazawa Medical University, Ishikawa, Japan
² Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan
³ Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan
⁴ Department of Epidemiology and Environmental Health, Juntendo University School of Medicine, Tokyo, Japan

Correspondence to:
Correspondence to:
Dr K Miura
Department of Epidemiology and Public Health, Kanazawa Medical University, 1–1 Daigaku, Uchinada, Ishikawa 920–0293, Japan; miura{at}kanazawa-med.ac.jp

ABSTRACT
Objective: To investigate prognosis and prognostic factors in patients with hypertrophic cardiomyopathy (HCM) in Japan.

Design: A nationwide epidemiological study.

Setting: Hospitals selected randomly from among all hospitals in Japan.

Patients: Clinical and epidemiological information for 2155 patients with HCM were collected in 1999.

Main outcome measures: Patients were classified on the basis of baseline prognostic factors. Survival rates up to 5 years were calculated by Cox’s proportional hazard model for 1605 patients.

Results: During the follow-up period, 241 deaths were recorded. The crude 5-year survival rate for the entire cohort was 86% (95% CI 84 to 88), and annual mortality ranged from 2.2% to 3.0%. A higher cardiothoracic ratio on chest x ray (HR 1.61; 95% CI 1.26 to 2.05, with 1 SD (6.2%) increase), a lower left ventricular ejection fraction (HR 1.42; 95% CI 1.20 to 1.69, with 1 SD (13%) decrease) and the presence of left bundle branch block (HR 3.14; 95% CI 1.28 to 7.71) were independently associated with a poorer prognosis, whereas the presence of apical hypertrophy at baseline (HR 0.58; 95%CI 0.36 to 0.92) predicted a better chance of survival.

Conclusions: The nationwide survey of patients with hypertrophic cardiomyopathy yielded important information on its prognosis and prognostic factors. These observations afford, for the first time, a measure of risk stratification in patients with HCM in Japan.

Abbreviations: AF, atrial fibrillation; BMI, body mass index; HCM, hypertrophic cardiomyopathy; IVS, interventricular septum; LBBB, left bundle branch block; LVEF, left ventricular ejection fraction; LV, left ventricular; NYHA, New York Heart Association